Chester County News and Community Website
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) reported second-quarter 2025 revenue of $12.7 million, driven by continued commercial momentum for its lead product, YCANTH®, and milestone payments from …
Verrica Pharmaceuticals Posts Strong Q2 Growth, Advances Basal Cell Carcinoma Program Read More
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) reported a strong second quarter for 2025, delivering $20.2 million in revenue, up 26% from the same period last year and 9% …
TELA Bio Posts Double-Digit Revenue Growth, Expands Product Reach in Q2 Read More
WEST CHESTER, PA — QVC Group, Inc. (Nasdaq: QVCGA, QVCGP; OTCQB: QVCGB) reported a steep second quarter loss, driven by a $2.4 billion non-cash impairment charge, as sales fell amid …
QVC Group Posts $2.3 Billion Loss on Impairment Charge as Revenue Declines Read More
WAYNE, PA — Ecovyst Inc. (NYSE: ECVT) posted second-quarter 2025 sales of $200.1 million, up from $182.8 million a year earlier, driven by stronger pricing in its Ecoservices segment and …
Ecovyst Reports Solid Q2 2025, Tightens Full-Year Guidance Read More
WAYNE, PA — Trinseo (NYSE: TSE) posted a deeper loss in the second quarter of 2025 as soft demand, pricing pressure, and reduced plant utilization weighed on results across all …
Trinseo Reports Wider Q2 Loss as Demand Weakens Across Markets Read More
EXTON, PA — Innovative Solutions & Support, Inc. (Nasdaq: ISSC) will release its third-quarter 2025 financial results before U.S. markets open on Thursday, August 14. The company will host a …
Innovative Solutions & Support to Announce Q3 Results on August 14 Read More
EXTON, PA — Bentley Systems, Incorporated (Nasdaq: BSY) reported solid second-quarter results, with revenue climbing more than 10% year-over-year and recurring revenue metrics showing continued momentum.
Bentley Systems Delivers Double-Digit Growth in Q2, Maintains Strong 2025 Outlook Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) reported a second-quarter net loss of $15.4 million and a year-to-date loss of $30.5 million, as the company continues to invest in advancing …
Aclaris Therapeutics Reports Q2 Loss, Highlights Progress in Immuno-Dermatology Pipeline Read More
MALVERN, PA — Vishay Intertechnology, Inc. (NYSE: VSH) reported second-quarter revenue of $762.3 million, marking a 7% sequential increase as both semiconductor and passive component sales saw improvement across all major …
Vishay Intertechnology Posts Modest Q2 Growth, Signals Optimism Amid Market Recovery Read More
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) delivered a solid second quarter, posting $38.1 million in total revenue—an 18% increase on an adjusted pro forma basis—as the company continues to benefit …
Neuronetics Posts Strong Q2 Revenue Growth, Secures $10M in New Funding as Greenbrook Integration Advances Read More